Platform Technology for Developing Purification Processes - A structural approach to resin screening and process optimization can accelerate the development of purification platforms. - BioPharm

ADVERTISEMENT

Platform Technology for Developing Purification Processes
A structural approach to resin screening and process optimization can accelerate the development of purification platforms.


BioPharm International Supplements


References

1. Frost & Sullivan. Strategic analysis of world downstream processing markets in biopharmaceutical production. 2004.

2. Wang T, John S, Archuleta S, Jonsson CB. Rapid, high-throughput purification of HIV-1 integrase using microtiter plate technology, Protein Expres Purif. 2004;33:232–37.

3. Eeckhout D, De Clercq A, Van de Slijke E, Van Leene J, Sals H, Casteels P, et al. A technology platform for the fast production of monoclonal recombinant antibodies against plant proteins and peptides. J Immunol Methods. 2004;294:181–7.

4. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis. 2000;21: 1164–77.

5. Weinberger SR, Viner RI, Ho P. Tagless extractionretentate chromatography: A new global protein digestion strategy for monitoring differential protein expression. Electrophoresis. 2002;23:3182–92.

6. Seibert V, Ebert MPA, Buschmann T. Advances in clinical cancer proteomics: SELDI–T–of-mass spectrometry and biomarker discovery. Br Funct Genomic Proteomic. 2005;4:16–26.

7. Seibert V, Wiesner A, Buschmann T, Meuer J. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF–MS) and ProteinChip technology in proteomics research. Pathol Res Pract. 2004;200:83–94.

8. Montgomery DC. Design and Analysis of Experiments. New York, NY: Wiley & Sons, Inc;2001.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here